1.
Fayez H, Elsherif M, Salem S, Elsharkawy N, Elnashar A, Kamal M, et al. Balancing benefit and burden: treatment intensification in paediatric KMT2A rearrangements acute myeloid leukaemia: KMT2A Rearrangements in Pediatric Intermediate-Risk Acute Myeloid Leukemia. AO [Internet]. 2025 Sep. 18 [cited 2026 May 16];64:1227-36. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/43878